Swedbank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.7M Buy
97,588
+3,794
+4% +$745K 0.02% 394
2026
Q1
$18.4M Buy
93,794
+326
+0.3% +$63.3K 0.02% 391
2025
Q4
$16.2M Buy
93,468
+8,605
+10% +$1.57M 0.02% 423
2025
Q3
$16.2M Hold
84,863
0.02% 419
2025
Q2
$15.2M Hold
84,863
0.02% 414
2025
Q1
$14.4M Hold
84,863
0.02% 413
2024
Q4
$12.8M Hold
84,863
0.02% 428
2024
Q3
$13.2M Buy
84,863
+19,570
+30% +$2.92M 0.02% 424
2024
Q2
$8.94M Hold
65,293
0.01% 452
2024
Q1
$8.69M Hold
65,293
0.08% 336
2023
Q4
$9M Hold
65,293
0.01% 451
2023
Q3
$7.96M Hold
65,293
0.01% 448
2023
Q2
$9.18M Hold
65,293
0.02% 432
2023
Q1
$9.24M Hold
65,293
0.02% 432
2022
Q4
$10.2M Sell
65,293
-107,349
-62% -$15.4M 0.02% 424
2022
Q3
$21.2M Sell
172,642
-311
-0.2% -$41K 0.05% 291
2022
Q2
$23M Buy
172,953
+32,140
+23% +$4.38M 0.05% 274
2022
Q1
$19.3M Sell
140,813
-355
-0.3% -$49.5K 0.04% 337
2021
Q4
$24.2M Sell
141,168
-26,887
-16% -$4.09M 0.04% 309
2021
Q3
$24.4M Hold
168,055
0.05% 303
2021
Q2
$22.2M Hold
168,055
0.04% 321
2021
Q1
$21.6M Buy
+168,055
New +$20.7M 0.04% 314

Other funds holding DGX

Swedbank's DGX Position: Q2 2026 in Review

Swedbank increased its Quest Diagnostics (DGX) stake by 4% in Q2 2026, buying an estimated $745K and bringing the position to 97,588 shares worth $20.7M. The position accounts for 0.02% of the portfolio, ranked #394.

Swedbank first reported a position in DGX in Q1 2021 and has held it in 22 quarters since. The position peaked at $24.4M in Q3 2021. 380 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Swedbank held 97,588 shares of Quest Diagnostics worth $20.7M as of Q2 2026.
  • Swedbank bought 3,794 Quest Diagnostics shares in Q2 2026, an estimated $745K.
  • Quest Diagnostics made up 0.02% of Swedbank's portfolio in Q2 2026, its #394 holding.
  • Swedbank first reported a position in Quest Diagnostics in Q1 2021 and has held it in 22 quarters since.
  • Swedbank's Quest Diagnostics position peaked at $24.4M in Q3 2021.
  • 380 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.